Prostate cancer originates in the male prostate gland and has become one of the most common types of cancer. It typically remains confined in this region, however it may spread to other locations throughout the body. Risk of prostate cancer increases with age, family history, obesity, and ethnicity as black males are the most likely to develop prostate cancer. Treatment for prostate cancer includes radiation therapy, hormone therapy, surgery, and chemotherapy. Metastatic prostate cancer is diagnosed with the cancer has spread beyond the prostate gland to distant lymph nodes, bones, organs or tissues. Metastatic prostate cancer is considered an advanced form of this cancer, and there are no treatments to cure this form. However, various techniques for assisting in symptom relief and regulating the cancer spreading have surfaced over the last few years.
Metastatic Prostate Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Metastatic Prostate Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 2172 products for the study of Metastatic Prostate Cancer that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
Metastatic Prostate Cancer is also known as Carcinoma Of The Prostate Metastatic, Metastatic Prostate Carcinoma, Prostate Cancer Metastatic, Prostate Carcinoma Metastatic, Prostatic Cancer Metastatic.
![Immunocytochemistry/Immunofluorescence: DIO2 Antibody [NBP1-00178] - Analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton.Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing nuclear and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](https://images.novusbio.com/fullsize2/DIO2-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-00178-img0006.jpg)
![Immunohistochemistry-Frozen: DIO2 Antibody [NBP1-00178] - IHC analysis of DIO2 in cryo-sectioned Mouse Hippocampus using NBP1-00178 at 2ug/ml. Microwaved antigen retrieval with citrate buffer pH 4.5, HRP-staining.](https://images.novusbio.com/fullsize/DIO2-Antibody-Immunohistochemistry-Frozen-NBP1-00178-img0001.jpg)
![Immunohistochemistry-Paraffin: GnRH Antibody [NB300-506] - Immunolocalization of GnRH in mouse embryo brain.](https://images.novusbio.com/fullsize2/GnRH-Antibody-Immunohistochemistry-Paraffin-NB300-506-img0004.jpg)
![Immunohistochemistry-Paraffin: GnRH Antibody [NB300-506] - Analysis of Hyla cinerea (green treefrog) forebrain using GnRH Polyclonal Antibody. Tissues were blocked in 10% normal goat serum in 0.1M PBS and then stained. Staining was developed with DAB substrate for 10 minutes. Data courtesy of Innovators Program.](https://images.novusbio.com/fullsize2/GnRH-Antibody-Immunohistochemistry-Paraffin-NB300-506-img0005.jpg)
![Western Blot: PSAT1 Antibody [NBP1-32920] - Various whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with PSAT1 antibody [N1C3] diluted at 1:1000.](https://images.novusbio.com/fullsize2/PSAT1-Antibody-Western-Blot-NBP1-32920-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: PSAT1 Antibody [NBP1-32920] - Paraformaldehyde-fixed A549, using antibody at 1:200 dilution.](https://images.novusbio.com/fullsize2/PSAT1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-32920-img0003.jpg)
![Western Blot: PSMA/FOLH1/NAALADase I Antibody (GCP-04) [NBP1-45057] - Analysis of human PSMA using mouse monoclonal antibody GCP-04 on lysates of LNCaP cell line and Jurkat cell line (PSMA non-expressing cell line; negative control) under reducing and non-reducing conditions. Nitrocellulose membrane was probed with 2 ug/ml of mouse anti-PSMA monoclonal antibody followed by IRDye800-conjugated anti-mouse secondary antibody.](https://images.novusbio.com/fullsize2/PSMA-FOLH1-NAALADase-I-Antibody-(GCP-04)-Western-Blot-NBP1-45057-img0011.jpg)
![Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (GCP-04) [NBP1-45057] - GCPII in porcine kidney by GCP-04 monoclonal antibody. Highly positive proximal glomeruli.](https://images.novusbio.com/fullsize2/PSMA-FOLH1-NAALADase-I-Antibody-(GCP-04)-Immunohistochemistry-Paraffin-NBP1-45057-img0008.jpg)
![Western Blot: Cbx8 Antibody [NBP1-83224] - Analysis in human cell line A-549.](https://images.novusbio.com/fullsize2/Cbx8-Antibody-Western-Blot-NBP1-83224-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: Cbx8 Antibody [NBP1-83224] - Staining of human cell line A-431 shows localization to nucleoplasm. Antibody staining is shown in green.](https://images.novusbio.com/fullsize2/Cbx8-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-83224-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: AKR1B1 Antibody [NBP1-89146] - Staining of human cell line A-431 shows localization to nucleoplasm & cytosol. Antibody staining is shown in green.](https://images.novusbio.com/fullsize2/AKR1B1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89146-img0006.jpg)
![Immunohistochemistry-Paraffin: AKR1B1 Antibody [NBP1-89146] - Staining of human liver shows no positivity in hepatocytes as expected.](https://images.novusbio.com/fullsize2/AKR1B1-Antibody-Immunohistochemistry-Paraffin-NBP1-89146-img0016.jpg)
![Western Blot: Androgen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) [NB100-56603] - Analysis using Azide Free version of NB100-56603. LNCaP cells (passage number 38) were serum-starved for 2 days. After serum starvation, cells were (A) left untreated, (B) treated with 100 ng/ml IGF-1 for 4h, or (C) incubated with 20 um LY294002 for 30 mi](https://images.novusbio.com/fullsize2/Androgen-R-NR3C4-[p-Ser213--p-Ser210]-Antibody-(156C135.2)-Western-Blot-NB100-56603-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: Puromycin-sensitive aminopeptidase/NPEPPS Antibody [NBP2-13669] - Immunofluorescent staining of human cell line A549 shows localization to cytosol.](https://images.novusbio.com/fullsize2/Puromycin-sensitive-aminopeptidase-NPEPPS-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-13669-img0003.jpg)
![Immunohistochemistry-Paraffin: Puromycin-sensitive aminopeptidase/NPEPPS Antibody [NBP2-13669] - Staining of human testis shows weak to moderate cytoplasmic positivity in Leydig cells and in cells in seminiferous ducts.](https://images.novusbio.com/fullsize2/Puromycin-sensitive-aminopeptidase-NPEPPS-Antibody-Immunohistochemistry-Paraffin-NBP2-13669-img0008.jpg)
![Western Blot: ACTR1B Antibody [NBP2-15275] - Sample (30 ug of whole cell lysate) A: IMR32 10% SDS PAGE; antibody diluted at 1:1000.](https://images.novusbio.com/fullsize2/ACTR1B-Antibody-Western-Blot-NBP2-15275-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: ACTR1B Antibody [NBP2-15275] - SKNSH cells were fixed in ice-cold MeOH for 5 min. Green: ACTR1B protein stained by ACTR1B antibody diluted at 1:1000. Blue: Hoechst 33342 staining.](https://images.novusbio.com/fullsize2/ACTR1B-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-15275-img0004.jpg)
![Western Blot: Ferredoxin Reductase Antibody [NBP2-38530] - Analysis in human cell lines A-549 and U-251MG using anti-FDXR antibody. Corresponding FDXR RNA-seq data are presented for the same cell lines. Loading control: anti-GAPDH.](https://images.novusbio.com/fullsize2/Ferredoxin-Reductase-Antibody-Western-Blot-NBP2-38530-img0008.jpg)
![Immunohistochemistry-Paraffin: Ferredoxin Reductase Antibody [NBP2-38530] - Staining in human adrenal gland and lymph node tissues using NBP2-38530 antibody. Corresponding FDXR RNA-seq data are presented for the same tissues.](https://images.novusbio.com/fullsize2/Ferredoxin-Reductase-Antibody-Immunohistochemistry-Paraffin-NBP2-38530-img0019.jpg)
![Kallikrein 3/PSA [HRP]](https://images.novusbio.com/fullsize2/DATA_Kallikrein_3_DKK300_ELISA_729.jpg)
![Kallikrein 3/PSA [HRP]](https://images.novusbio.com/fullsize2/DATA_Kallikrein_3_DKK300_ELISA_730.jpg)
![VEGF [HRP]](https://images.novusbio.com/fullsize2/DATA_VEGF_DVE00_ELISA_871.jpg)
![VEGF [HRP]](https://images.novusbio.com/fullsize2/DATA_VEGF_DVE00_ELISA_872.jpg)
![IL-6 [HRP]](https://images.novusbio.com/fullsize2/IL6_D6050_ELISA_2663.jpg)
![IL-6 [HRP]](https://images.novusbio.com/fullsize2/IL6_D6050_ELISA_2664.jpg)
![Amphiregulin [Biotin]](https://images.novusbio.com/fullsize2/DATA_Amphiregulin_DY262_ELISA_1858.jpg)
![Western Blot: BTG1 Antibody (4C10) [NBP2-46587] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTG 1.](https://images.novusbio.com/fullsize2/BTG1-Antibody-(4C10)-Western-Blot-NBP2-46587-img0006.jpg)
![Immunohistochemistry: BTG1 Antibody (4C10) [NBP2-46587] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](https://images.novusbio.com/fullsize2/BTG1-Antibody-(4C10)-Immunohistochemistry-NBP2-46587-img0005.jpg)
![Western Blot: Proprotein Convertase 1/PCSK1 Antibody (3D2) [H00005122-M02] - PCSK1 monoclonal antibody (M02), clone 3D2. Analysis of PCSK1 expression in Raw 264.7.](https://images.novusbio.com/fullsize2/Proprotein-Convertase-1-PCSK1-Antibody-(3D2)-Western-Blot-H00005122-M02-img0016.jpg)
![Immunocytochemistry/Immunofluorescence: Proprotein Convertase 1/PCSK1 Antibody (3D2) [H00005122-M02] - Analysis of monoclonal antibody to PCSK1 on HeLa cell. Antibody concentration 30 ug/ml.](https://images.novusbio.com/fullsize2/Proprotein-Convertase-1-PCSK1-Antibody-(3D2)-Immunocytochemistry-Immunofluorescence-H00005122-M02-img0010.jpg)
![Western Blot: PLAG1 Antibody (3B7) [H00005324-M02] - Western Blot detection against Immunogen (36.52 KDa) .](https://images.novusbio.com/fullsize2/PLAG1-Antibody-(3B7)-Western-Blot-H00005324-M02-img0002.jpg)
![Immunohistochemistry: PLAG1 Antibody (3B7) [H00005324-M02] - Left, IHC showing TGFBR3 staining in whole tumor sections (upper panels, scale bars=5mm) and enlargement of selected areas (lower panels, scale bars=100um). Right, quantification of IHC TGFBR3 levels in TGFBR3-PLAG1 positive vs. negative tumors. P (high TGFBR3)=0.002, Fisher's exact test. n=5+34. Image collected and cropped by CiteAb from the following publication (nature.com/articles/s41467-017-01178-z), licensed under a CC-BY licence.](https://images.novusbio.com/fullsize2/PLAG1-Antibody-(3B7)-Immunohistochemistry-H00005324-M02-img0005.jpg)
